Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Parents Jay and Kateri Schwandt did not want to know the sex of their latest child before his birth.
Windrush immigrants Sonia Williams and Glenda Caesar are the first two cases to be resolved by the Home Office task force.
Priyanka Chopra wrote of how the compassionate royal bride-to-be cares deeply for the world